Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 9 studies | 23% ± 6% | |
myeloid cell | 3 studies | 32% ± 7% | |
endothelial cell | 3 studies | 18% ± 2% |
Insufficient scRNA-seq data for expression of NR1H3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 4342.04 | 226 / 226 | 100% | 37.81 | 406 / 406 |
ovary | 99% | 1473.14 | 179 / 180 | 100% | 16.35 | 429 / 430 |
breast | 100% | 5306.02 | 459 / 459 | 99% | 20.48 | 1109 / 1118 |
prostate | 100% | 2167.11 | 244 / 245 | 100% | 14.07 | 500 / 502 |
thymus | 100% | 2305.31 | 652 / 653 | 99% | 14.57 | 601 / 605 |
lung | 99% | 2686.32 | 575 / 578 | 99% | 20.32 | 1149 / 1155 |
kidney | 99% | 2016.81 | 88 / 89 | 100% | 23.93 | 898 / 901 |
bladder | 100% | 2355.29 | 21 / 21 | 98% | 20.56 | 496 / 504 |
intestine | 99% | 2167.51 | 957 / 966 | 99% | 20.88 | 520 / 527 |
uterus | 100% | 1795.59 | 170 / 170 | 97% | 15.68 | 443 / 459 |
stomach | 96% | 1283.18 | 344 / 359 | 99% | 20.04 | 283 / 286 |
skin | 95% | 1147.97 | 1720 / 1809 | 97% | 22.48 | 458 / 472 |
pancreas | 91% | 885.06 | 300 / 328 | 97% | 22.88 | 172 / 178 |
brain | 77% | 574.00 | 2037 / 2642 | 100% | 15.44 | 704 / 705 |
esophagus | 86% | 992.38 | 1244 / 1445 | 88% | 9.57 | 161 / 183 |
adrenal gland | 99% | 1902.13 | 256 / 258 | 37% | 2.98 | 85 / 230 |
adipose | 100% | 5843.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 127.21 | 29 / 29 |
spleen | 100% | 5859.99 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.37 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 18.18 | 79 / 80 |
tonsil | 0% | 0 | 0 / 0 | 93% | 16.42 | 42 / 45 |
heart | 90% | 1071.23 | 778 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 84% | 1057.66 | 1126 / 1335 | 0% | 0 | 0 / 0 |
muscle | 53% | 403.76 | 426 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 21% | 156.27 | 197 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0055092 | Biological process | sterol homeostasis |
GO_0070328 | Biological process | triglyceride homeostasis |
GO_0043031 | Biological process | negative regulation of macrophage activation |
GO_0036151 | Biological process | phosphatidylcholine acyl-chain remodeling |
GO_0051247 | Biological process | positive regulation of protein metabolic process |
GO_0010887 | Biological process | negative regulation of cholesterol storage |
GO_0045723 | Biological process | positive regulation of fatty acid biosynthetic process |
GO_0090341 | Biological process | negative regulation of secretion of lysosomal enzymes |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0060336 | Biological process | negative regulation of type II interferon-mediated signaling pathway |
GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0010867 | Biological process | positive regulation of triglyceride biosynthetic process |
GO_1903573 | Biological process | negative regulation of response to endoplasmic reticulum stress |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0032376 | Biological process | positive regulation of cholesterol transport |
GO_0048550 | Biological process | negative regulation of pinocytosis |
GO_0010745 | Biological process | negative regulation of macrophage derived foam cell differentiation |
GO_0032369 | Biological process | negative regulation of lipid transport |
GO_0043277 | Biological process | apoptotic cell clearance |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0034145 | Biological process | positive regulation of toll-like receptor 4 signaling pathway |
GO_0030154 | Biological process | cell differentiation |
GO_0010875 | Biological process | positive regulation of cholesterol efflux |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0051006 | Biological process | positive regulation of lipoprotein lipase activity |
GO_0032411 | Biological process | positive regulation of transporter activity |
GO_0090188 | Biological process | negative regulation of pancreatic juice secretion |
GO_0055088 | Biological process | lipid homeostasis |
GO_0032570 | Biological process | response to progesterone |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0043235 | Cellular component | receptor complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0015485 | Molecular function | cholesterol binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0032810 | Molecular function | sterol response element binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NR1H3 |
Protein name | Nuclear receptor subfamily 1 group H member 3 Liver X nuclear receptor alpha variant 1 Liver X receptor alpha Nuclear receptor subfamily 1 group H member 3 (cDNA FLJ56172, highly similar to Oxysterols receptor LXR-alpha) Oxysterols receptor LXR-alpha (Liver X receptor alpha) (Nuclear receptor subfamily 1 group H member 3) |
Synonyms | LXRA |
Description | FUNCTION: Nuclear receptor that exhibits a ligand-dependent transcriptional activation activity . Interaction with retinoic acid receptor (RXR) shifts RXR from its role as a silent DNA-binding partner to an active ligand-binding subunit in mediating retinoid responses through target genes defined by LXRES (By similarity). LXRES are DR4-type response elements characterized by direct repeats of two similar hexanuclotide half-sites spaced by four nucleotides (By similarity). Plays an important role in the regulation of cholesterol homeostasis, regulating cholesterol uptake through MYLIP-dependent ubiquitination of LDLR, VLDLR and LRP8 . Interplays functionally with RORA for the regulation of genes involved in liver metabolism (By similarity). Induces LPCAT3-dependent phospholipid remodeling in endoplasmic reticulum (ER) membranes of hepatocytes, driving SREBF1 processing and lipogenesis (By similarity). Via LPCAT3, triggers the incorporation of arachidonate into phosphatidylcholines of ER membranes, increasing membrane dynamics and enabling triacylglycerols transfer to nascent very low-density lipoprotein (VLDL) particles. Via LPCAT3 also counteracts lipid-induced ER stress response and inflammation, likely by modulating SRC kinase membrane compartmentalization and limiting the synthesis of lipid inflammatory mediators (By similarity). . |
Accessions | C9J2C8 C9JTS4 C9JEC2 C9JJ16 E9PLL4 F8WC63 ENST00000407404.5 [Q13133-2] ENST00000412937.5 ENST00000481889.6 ENST00000405853.7 [Q13133-2] ENST00000395397.7 [Q13133-3] E9PID2 Q13133 ENST00000420369.5 ENST00000441012.7 [Q13133-1] ENST00000405576.5 ENST00000457932.5 ENST00000444396.5 C9J4R0 ENST00000616973.4 ENST00000436029.5 F1D8N1 B6ZGS8 ENST00000467728.5 [Q13133-1] ENST00000437276.1 ENST00000527949.1 ENST00000531660.5 C9JBS2 E9PPA1 ENST00000419652.5 B5MBY7 ENST00000449369.5 C9JCS0 F8WEY6 B4DXU5 ENST00000436778.5 |